Relpax price
Executive Summary
Pfizer launches migraine agent Relpax (eletriptan) at $15.80 per tablet; packages of 12 tablets of either strength (20 mg or 40 mg) list for $189.60 AWP. The price is a slight discount to GSK's Imitrex (sumatriptan), which lists for $17.17 per 50 mg tablet. FDA approved Relpax Dec. 26 (1"The Pink Sheet" Jan. 6, p. 5)...
You may also be interested in...
Pfizer Relpax To Launch In First Quarter At Maximum Dose Of 40 Mg
Pfizer's Relpax migraine treatment will be launched during the first quarter at a maximum dose of 40 mg
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.